Severe myocarditis due to influenza A(H1N1)pdm09 viral infection in a young woman successfully treated with intravenous zanamivir: A case report

In patients with influenza‐related myocarditis, prompt diagnosis and treatment are important. Intravenous zanamivir can be an alternative to oral oseltamivir, especially in severe cases and when drug intestinal malabsorption is suspected or proven.

[1]  L. Pisani,et al.  High-Flow Oxygen Therapy After Noninvasive Ventilation Interruption in Patients Recovering From Hypercapnic Acute Respiratory Failure: A Physiological Crossover Trial , 2019, Critical care medicine.

[2]  C. Gregoretti,et al.  Early extubation followed by immediate noninvasive ventilation vs. standard extubation in hypoxemic patients: a randomized clinical trial , 2018, Intensive Care Medicine.

[3]  L. Liaudet,et al.  Intravenous zanamivir for influenza myocarditis and enteral malabsorption , 2018, Critical Care.

[4]  G. Gao,et al.  Development of a quadruple qRT-PCR assay for simultaneous identification of highly and low pathogenic H7N9 avian influenza viruses and characterization against oseltamivir resistance , 2018, BMC Infectious Diseases.

[5]  P. Póvoa,et al.  Intensive care unit patients with lower respiratory tract nosocomial infections: the ENIRRIs project , 2017, ERJ Open Research.

[6]  F. Hayden,et al.  The hidden burden of influenza: A review of the extra‐pulmonary complications of influenza infection , 2017, Influenza and other respiratory viruses.

[7]  M. Hosoya,et al.  Influenza A H1N1 pdm09‐associated myocarditis during zanamivir therapy , 2015, Pediatrics international : official journal of the Japan Pediatric Society.

[8]  Tiina Heliö,et al.  Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2013, European heart journal.

[9]  A. Ukimura,et al.  A national survey on myocarditis associated with influenza H1N1pdm2009 in the pandemic and postpandemic season in Japan , 2013, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[10]  A. Menkis,et al.  Influenza myocarditis and myositis: case presentation and review of the literature. , 2011, The Canadian journal of cardiology.

[11]  G. Nardi,et al.  Prone Positioning and Intravenous Zanamivir may Represent Effective Alternatives for Patients with Severe ARDS Virus A (H1N1) Related Pneumonia in Hospitals with no Access to ECMO , 2010, Critical care research and practice.

[12]  A. Matsumori,et al.  A national survey on myocarditis associated with the 2009 influenza A (H1N1) pandemic in Japan. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[13]  S. Kashiwagi,et al.  Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  Nicholas J. White,et al.  Oseltamivir Is Adequately Absorbed Following Nasogastric Administration to Adult Patients with Severe H5N1 Influenza , 2008, PloS one.

[15]  H. Rehder,et al.  Partial trisomy 1q syndrome , 1979, Clinical genetics.